-
Core Laboratories (CLB) PT Lowered to $95 at RBC Capital
-
Core Laboratories (CLB) PT Lowered to $130 at RBC Capital, Sees Weakness as Buying Opportunity
-
Core Laboratories (CLB) PT Raised to $135 at RBC Capital
-
RBC Capital Upgrades Core Laboratories (CLB) to Outperform
-
Pre-Open Stock Movers 04/23: (ARRS) (DNKN) (SKX) Higher; (MOBL) (MTH) (TXN) Lower (more...)
-
After-Hours Stock Movers 4/22: (AFOP) (EBAY) (CAKE) Higher; (TXN) (LVS) (FB) Lower (more..)
-
RBC Capital Downgrades Core Laboratories (CLB) to Sector Perform